共 31 条
- [2] Retargeting NK-92 cells by means of CD19-and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity [J]. ONCOIMMUNOLOGY, 2013, 2 (10):
- [4] A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (07): : 799 - 806
- [9] Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7